AMRX - Amneal Pharmaceuticals Inc. (AMRX) CEO Chintu Patel on Q2 2021 Results - Earnings Call Transcript

Amneal Pharmaceuticals, Inc. (AMRX) Q2 2021 Earnings Conference Call August 09, 2021 08:00 AM ET Company Participants Tony DiMeo - Head of Investor Relations Chirag Patel - Co-Chief Executive Officer Chintu Patel - Co-Chief Executive Officer Tasos Konidaris - Chief Financial Officer Andy Boyer - Chief Commercial Officers, Generics & Specialty segments Joe Todisco - Chief Commercial Officers, Generics & Specialty segments Conference Call Participants Gary Nachman - BMO Capital Markets David Amsellem - Piper Sandler Balaji Prasad - Barclays Greg Fraser - Truist Securities Daniel Busby - RBC Capital Markets Presentation Operator Good morning, and welcome to Amneal's Second Quarter 2021 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Amneal's Head of Investor Relations, Tony DiMeo. Please go ahead. Tony DiMeo Good morning, and thank you for joining Amneal's

For further details see:

Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q2 2021 Results - Earnings Call Transcript